PMID- 31142414
OWN - NLM
STAT- MEDLINE
DCOM- 20200103
LR  - 20200103
IS  - 1681-7168 (Electronic)
IS  - 1022-386X (Linking)
VI  - 29
IP  - 6
DP  - 2019 Jun
TI  - Primary Extra-renal Wilms' Tumor in Urinary Bladder: Rare Presentation of a 
      Common Pediatric Malignancy.
PG  - S31-S33
LID - 10.29271/jcpsp.2019.06.S31 [doi]
AB  - In pediatric population, the most common solid malignant tumor of the kidney is 
      Wilms' tumor (WT). Incidence of Extra-Renal Wilms' Tumor (ERWT) is immensely 
      unusual. Prognosis of ERWT is comparable to renal WT. Hence, diagnosis, staging 
      workup and start of treatment in a timely manner is very essential. The most 
      common location of ERWT is the retroperitoneum. The staging of ERWT is done 
      according to National Wilms' Tumor Study group (NWTS). ERWT is considered as 
      stage II or higher; because it is outside renal capsule. A 6-year boy presented 
      with complaints of increased frequency of micturition and difficulty in urination 
      for 15 months. Biopsy of bladder mass showed WT by immunohistochemistry stains 
      such as WTI and Desmin. Cross-sectional imaging showed both kidneys clear of any 
      tumor. Hence, the final diagnosis of ERWT was made.
FAU - Sindhu, Irfana Ishaq
AU  - Sindhu II
AD  - Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and 
      Research Centre, Lahore, Pakistan.
FAU - Saeed, Haleema
AU  - Saeed H
AD  - Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and 
      Research Centre, Lahore, Pakistan.
FAU - Wali, Rabia
AU  - Wali R
AD  - Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and 
      Research Centre, Lahore, Pakistan.
FAU - Mehreen, Asma
AU  - Mehreen A
AD  - Department of Pediatric Oncology, Shaukat Khanum Memorial Cancer Hospital and 
      Research Centre, Lahore, Pakistan.
LA  - eng
PT  - Case Reports
PL  - Pakistan
TA  - J Coll Physicians Surg Pak
JT  - Journal of the College of Physicians and Surgeons--Pakistan : JCPSP
JID - 9606447
RN  - 0 (Antibiotics, Antineoplastic)
RN  - 1CC1JFE158 (Dactinomycin)
RN  - 5J49Q6B70F (Vincristine)
RN  - 80168379AG (Doxorubicin)
SB  - IM
MH  - Antibiotics, Antineoplastic/therapeutic use
MH  - Antineoplastic Combined Chemotherapy Protocols/administration & dosage
MH  - Biopsy
MH  - Child
MH  - Combined Modality Therapy
MH  - Dactinomycin/therapeutic use
MH  - Doxorubicin/therapeutic use
MH  - Humans
MH  - Kidney/diagnostic imaging
MH  - Kidney Neoplasms/*pathology/therapy
MH  - Male
MH  - Neoplasm Staging
MH  - Radiotherapy
MH  - Treatment Outcome
MH  - *Ultrasonography
MH  - Ureter/diagnostic imaging
MH  - Urinary Bladder/*diagnostic imaging
MH  - Vincristine/therapeutic use
MH  - Wilms Tumor/*pathology/therapy
EDAT- 2019/05/31 06:00
MHDA- 2020/01/04 06:00
CRDT- 2019/05/31 06:00
PHST- 2018/08/10 00:00 [received]
PHST- 2019/01/03 00:00 [accepted]
PHST- 2019/05/31 06:00 [entrez]
PHST- 2019/05/31 06:00 [pubmed]
PHST- 2020/01/04 06:00 [medline]
AID - 040579197 [pii]
AID - 10.29271/jcpsp.2019.06.S31 [doi]
PST - ppublish
SO  - J Coll Physicians Surg Pak. 2019 Jun;29(6):S31-S33. doi: 
      10.29271/jcpsp.2019.06.S31.